Bicarbonate

Bicarbonate

SCHEMBL472826

O=C([O-])[O-].O=C([O-])[O-].[Ni+2].[Ni+2].[Ni+2].[OH-].[OH-]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CA4 P22748 5/20 0.46
CA1 P00915 3/20 0.46
FAHD1 Q6P587 1/20 0.46
LMNA P02545 2/20 0.36
MEN1 O00255 1/20 0.36
LDHA P00338 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36
CASP1 P29466 1/20 0.33
CA2 P00918 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL29577271 0.94
Bicarbonate SCHEMBL6580033 0.94 CA4 (0.42) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL2023098 0.94 CA4 (0.42) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL6750021 0.94 CA4 (0.42) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL9950130 0.94 CA4 (0.42) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL7719205 0.94 CA4 (0.42) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL29575457 0.94
Bicarbonate SCHEMBL10907035 0.94 CA4 (0.42) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL6577630 0.94 CA4 (0.42) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL138735 0.94 CA4 (0.50) CA4CA1FAHD1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 228 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113559884-A Hydrogenation catalyst for sulfurized heavy oil and its preparing process and application 中国石油化工股份有限公司 2021-10-29 CN claimed
CN-112735855-A Alkaline nickel-cobalt carbonate and manganese dioxide core-shell structure supercapacitor composite electrode material loaded with foamed nickel and preparation method thereof 吉林大学 2021-04-30 CN claimed
US-10788722-B2 Electrochromic devices and method for forming such devices CLEARIST INC. (US) 2020-09-29 US claimed
US-20170075182-A1 ELECTROCHROMIC DEVICES AND METHOD FOR FORMING SUCH DEVICES CLEARIST INC. 2017-03-16 US claimed
WO-2014119943-A1 METHOD FOR FABRICATING LARGE METAL NANOFIBER ELECTRODE ARRAY USING ALIGNED METAL NANOFIBER 포항공과대학교 산학협력단 (KR) 2014-08-07 WO claimed
EP-1412284-A2 COMPOSITION FOR TREATING CELLS AND METHODS FOR QUALITATIVELY AND QUANTITATIVELY CUSTOMIZING THE FORMULATION THEREOF FOR A HEURISTICALLY DERIVED LIVING CELL NUTRIENT-COMPOSITION-ON-DEMAND Runkis, Walter H. (US) 2004-04-28 EP claimed
CN-1125679-C Hydrogenation catalyst and preparation method thereof LOYNA WILK CO LTD (DE) 2003-10-29 CN claimed
CN-1125678-C functional group hydrogenation catalyst and preparation method thereof LOYNA WILK CO LTD (DE) 2003-10-29 CN claimed
US-20030073580-A1 Composition for treating cells and method for qualitatively and quantitatively customizing the formulation thereof RUNKIS WALTER H (US) 2003-04-17 US claimed
US-6508995-B1 Reducing melting temperature by formation of copper, nickel or zinc diamine complex optionally with water inclusion FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) 2003-01-21 US claimed
WO-2002100772-A2 COMPOSITION AND METHOD FOR TREATING CELLS AND PLANTS RUNKIS WALTER H (US) 2002-12-19 WO claimed
CN-1349433-A Nickel catalyst for hydrogenating functional groups and method for producing same LOYNA WILK CO LTD (DE) 2002-05-15 CN claimed
CN-1349434-A Hydrogenating catalyst and method for producing the same LOYAN WILK CO LTD (DE) 2002-05-15 CN claimed
EP-0114704-B2 Nickel-based catalyst, its preparation and its application UNILEVER NV (NL) 1995-01-04 EP claimed
US-4670416-A RAPID PRECIPITATION; SILICA INTERNATIONALE OCTROOI MAATSCHAPPIJ"OCTROPA"B.V. (NL) 1987-06-02 US claimed
EP-0114704-B1 NICKEL-BASED CATALYST, ITS PREPARATION AND ITS APPLICATION UNILEVER N.V. (NL) 1986-07-02 EP claimed
EP-0114704-A2 Nickel-based catalyst, its preparation and its application UNILEVER N.V. (NL) 1984-08-01 EP claimed
US-4371573-A Electroless deposition of nickel coatings and depositing baths therefor SIEMENS AKTIENGESELLSCHAFT (DE) 1983-02-01 US claimed
US-20260125603-A1 ISOMERIZATION OF BIOFEEDS OVER BASE METAL CATALYSTS EXXONMOBIL TECHNOLOGY AND ENGINEERING CO (US) 2026-05-07 US disclosed
US-4371573-A Electroless deposition of nickel coatings and depositing baths therefor SIEMENS AKTIENGESELLSCHAFT (DE) 1983-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125603-A1 ISOMERIZATION OF BIOFEEDS OVER BASE METAL CATALYSTS CYP4F8, SLC6A12, DBF4 CA4 78/4885CA1 109/4885FAHD1 1683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.